Amgen's experimental Sjogren's drug meets late-stage trial goal

Amgen's experimental Sjogren's drug meets late-stage trial goal

来源:Reuters发布于 2026-11-11

Amgen said on ‌Wednesday its ​experimental ​drug showed ⁠sustained ​reduction in ​disease activity in ​a ​late-stage study ‌of ⁠patients with Sjogren's ​disease, ​an ⁠autoimmune condition.

相关标的:AMGN

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。